MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer
Frontiers in Nuclear Medicine · 29.07.2026 · 6
DOI: 10.3389/fnume.2026.1854064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nuclear Medicine, online erschienen am 29.07.2026. Verfasst von Michael Courtney und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, St. James's Hospital, Dublin, Ireland. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
We evaluated whether Magnetic Resonance Imaging (MRI)-Derived T Stage independently predicts nodal disease on Prostate-Specific Membrane Antigen (PSMA) PET/CT in patients with high-risk primary prostate cancer, and developed a predictive model for clinical decision support. Materials and methods MRI-derived T Stage, Prostate-Specific Antigen (PSA), Gleason score, age and PSMA node status were analysed using univariable and multivariable logistic regression in 152 men with high-risk primary prostate cancer who underwent pre-treatment multiparametric MRI and PSMA PET/CT. Model performance was assessed with area under the receiver operating characteristic (ROC) curve (AUC), calibration plots, and decision curve analysis. Subgroup analyses evaluated Gleason 3 + 4 and 4 + 3 disease separately.
Results
MRI T3b and T4 stages were independently and significantly associated with increased risk of PSMA-positive nodal disease ( p < 0.001 and p = 0.016, respectively). T3a disease was not significantly independently associated with PSMA-positive nodal disease ( p = 0.086). T3b remained an independent predictor even in Gleason 4 + 3 cases ( p = 0.026; odds ratio ≈ 23.57). The final model (AUC = 0.863) was well-calibrated and demonstrated clinical net benefit on decision curve analysis. In our cohort, patients with PSA < 20 ng/mL, MRI-derived T2 disease, and Gleason score < 8 (including both 3 + 4 and 4 + 3 patterns) demonstrated a 0% rate of PSMA-positive nodal disease.
Conclusion
MRI-derived T stage T3b disease is a strong independent predictor of PSMA-positive nodal disease. These findings support guideline-based staging criteria and support the integration of MRI-derived T Stage into PSMA PET/CT triage workflows.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, St. James's Hospital, Dublin, Ireland.
Zitieren
APA
Courtney, M., Whiriskey, R., Johnston, C., & Sheehy, N. (2026). MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer. Frontiers in Nuclear Medicine, 6. https://doi.org/10.3389/fnume.2026.1854064
Vancouver
Courtney M, Whiriskey R, Johnston C, Sheehy N. MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer. Frontiers in Nuclear Medicine. 2026;6. doi:10.3389/fnume.2026.1854064
BibTeX
@article{Courtney2026,
author = {Courtney, Michael and Whiriskey, Robert and Johnston, Ciaran and Sheehy, Niall},
title = {MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer},
journal = {Frontiers in Nuclear Medicine},
year = {2026},
volume = {6},
doi = {10.3389/fnume.2026.1854064}
}
EUVIMED